Images List Premium Download Classic

Infectious

Infectious-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Mediated access to resources
Mimecast North America, Inc.
June 22, 2017 - N°20170180378

Today's user is facing an ever increasing number of cyber threats from infectious software to scam artist phishing for their passwords and other personal information. Accordingly, a technique is provided to mediate a user's access to electronic resources, which can include malware and sites that trick the user into giving their password. Based on information known about the resource at ...
Self assembling nucleic acid nanostructures
Exicure, Inc.
June 22, 2017 - N°20170175121

Stable self-assembling nucleic acid nanostructures comprising: —a plurality of oligonucleotides, —a plurality of g-quadruplex forming nucleic acids linked to the plurality of oligonucleotides, and —a plurality of g-quadruplex stabilizing domains linked to the g-quadruplex forming nucleic acids. The nucleic acid nanostructures are suitable for use as agonists or antagonists of nucleic acid interacting complexes, such as toll-like ...
Icos binding proteins
Glaxosmithkline Intellectual Property Development Limited
June 22, 2017 - N°20170174767

The present invention relates to an icos binding protein or antigen binding portion thereof that is an agonist to human icos and does not induce complement, adcc, or cdc when placed in contact with a t cell in vivo and methods of treating cancer, infectious disease and/or sepsis with said icos binding protein or antigen binding portion thereof. Further ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Live attenuated chimeric porcine circovirus vaccine
Virginia Tech Intellectual Properties, Inc.
June 22, 2017 - N°20170173143

The present invention provides a novel chimeric porcine circovirus infectious dna clone and live attenuated chimeric virus with the pcv2, preferably of subtype pcv2b, capsid gene integrated into a non-pathogenic pcv1 virus genome. In a particular embodiment, the pcv2 capids gene is of subtype pcv2b, the predominant subtype circulating in pigs worldwide. The attenuated chimeric virus, designated pcv1...
Har-nds-derived stem cells, method for separating same, and use thereof
Eutilex Co., Ltd
June 22, 2017 - N°20170173077

The present invention relates to hyaluronic acid-rich node and duct system (har-nds)-derived stem cells, a method for separating the same, and a use thereof and, more specifically, to node and ductal stem cells (ndscs), which are adult stem cells having an ability to differentiate into har-nds-derived neural cells, and hematopoietic stem cells having an ability to differentiate into blood ...
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
Platform Brightworks Two, Ltd.
June 22, 2017 - N°20170172971

There may be provided compositions of lipophilic pharmaceutical agents with improved solubility and stability. For example, there may be provided a non-aqueous composition that comprises a lipophilic pharmaceutical agent, and an amphiphilic polymeric solvent such as peg400 but essentially free of organic solvents and non-solubilized particles. The composition may be further diluted with a desired aqueous diluent such as an ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Systems and methods for detecting infectious diseases
Theranos, Inc.
June 15, 2017 - N°20170168051

Systems, methods, and devices for detecting infections in a clinical sample are provided. Small-volume clinical samples obtained at a point-of-service (pos) location and may be tested at the pos location for multiple markers for multiple diseases, including upper and lower respiratory diseases. Samples may be tested for cytokines, or for inflammation indicators. Dilution of samples, or levels of detection, may ...
Differential diagnostic method and kit for infectious and parasitic diseases, using flow cytometry
Fundacao Oswaldo Cruz
June 15, 2017 - N°20170168050

The present invention relates to a differential diagnostic method using flow cytometry, performed by means of differential fluorescent marking of biological agents, such as cells and pathogens of interest, with fluorescent substances. The diagnostic method generally consists in performing fluorescent marking of biological agents with gradual concentrations of fluorescent substances, and in analyzing the reactivity profile of igg1 to the ...
Dnazyme-nanoparticle conjugates and methods of use thereof
The University Of Notre Dame
June 15, 2017 - N°20170166890

The present invention relates to dnazymes (also known as deoxyribozymes, dna enzymes, catalytic dna, or dz), which are conjugated to nanoparticles (np) to facilitate the detection of nucleic acids. One aspect of the invention relates to compounds comprising dnazymes conjugated to nanoparticles (dz-np), such as metallic or gold nanoparticles, and methods for their synthesis. Another aspect of the invention relates ...
Immunological reagents
Mabquest Sa
June 15, 2017 - N°20170166642

This disclosure relates to binding agents with specificity for programmed cell death 1 (pd-1) and to methods for using the same to treat, prevent and/or ameliorate an infectious disease (e. G., human immunodeficiency virus (hiv)), cancer and/or autoimmunity. In addition, this disclosure identifies a novel binding patch (“p2”) on pd-1 that is linked with a ...
Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing ...
Druggability Technologies Ip Holdco Limited
June 15, 2017 - N°20170165237

The invention is directed to a stable complex with controlled particle size, increased apparent solubility and increased dissolution rate comprising as active compound sirolimus or derivatives thereof, which is useful in the prophylaxis of organ rejection in patients receiving renal transplants, in the treatment of psoriasis, facial angiofibromas associated with tuberous sclerosis, fibrofolliculomas found in birt-hogg-dubé syndrome, chronic erosive ...
Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t ...
Druggability Technologies Ip Holdco Limited
June 15, 2017 - N°20170165230

The present application generally relates to the discovery that glycogen synthase kinase 3 (gsk-3) is an upstream signalling molecule that controls pd-1 transcription and tbet expression by immune cells and in particular t-cells. Based on this discovery, and in view of the known immunosuppressive effect of pd-1 on immunity and the promoting effect of tbet on t cell immunity, the present ...
Intraocular delivery devices and methods therefor
Ocuject, Llc
June 15, 2017 - N°20170165113

Injection devices for delivering pharmaceutical compositions into the eye are described. Some devices include a resistance component for controllably deploying an injection needle through the eye wall. The resistance component may be disposed on a removable injector attachment or on a portion of the injection device housing. Other devices may include a filter for the removal of air, infectious agents, ...
Infectious Patent Pack
Download 268+ patent application PDFs
Infectious Patent Applications
Download 268+ Infectious-related PDFs
For professional research & prior art discovery
inventor
  • 268+ full patent PDF documents of Infectious-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Chemical gel to dissolve metal and hazardous medical sharps
Armour Technologies, Inc.
June 15, 2017 - N°20170165024

This dissolvent is an inorganic compound of silica gel that is stabile and lasts for decades. Pleasant gold color, no evident odor or vapor, and it will not spill, or degrade over the decades, while awaiting use. After full and complete use with several syringes needles being dissolved at one location, these sharps will blacken and corrode and dissolve away, ...
Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
E.r. Squibb & Sons, L. L. C.
June 08, 2017 - N°20170158767

The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to pd-l1 with high affinity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The ...
Novel compounds
E.r. Squibb & Sons, L. L. C.
June 08, 2017 - N°20170158724

And pharmaceutically acceptable salts and tautomers thereof, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, in the treatment of diseases in which modulation of sting (stimulator of interferon genes) is beneficial, for example inflammation, allergic and autoimmune diseases, infectious diseases, cancer, pre-cancerous ...
Protein kinase inhibitors
Pharmascience Inc.
June 08, 2017 - N°20170158697

The present invention relates to a novel family of protein kinase inhibitors, more specifically the present invention is directed to inhibitors of the members of the tec or src protein kinase families. The present invention also relates to processes for the preparation of these compounds, to the pharmaceutical composition comprising them, and to their use in the treatment of proliferative, ...
Conjugates of cell binding molecules with cytotoxic agents
Pharmascience Inc.
June 08, 2017 - N°20170157262

A conjugate of a potent cytotoxic agent with a cell-surface receptor binding molecule having a formula (i), wherein t, l, m, n, y, r1, r2, r3, r4, r5, r6, r7, r8, r9, r10, r12, and r13 are defined herein, can be used for targeted treatment of cancer, autoimmune disease, and infectious disease.
Replication-competent vesicular stomatitis viruses
Mayo Foundation For Medical Education And Research
June 08, 2017 - N°20170157187

This document provides methods and materials related to vesicular stomatitis viruses. For example, replication-competent vesicular stomatitis viruses, nucleic acid molecules encoding replication-competent vesicular stomatitis viruses, methods for making replication-competent vesicular stomatitis viruses, and methods for using replication-competent vesicular stomatitis viruses to treat cancer or infectious diseases are provided.
Time zero classification of messages
Dell Software Inc.
June 01, 2017 - N°20170155670

Detecting infectious messages comprises performing an individual characteristic analysis of a message to determine whether the message is suspicious, determining whether a similar message has been noted previously in the event that the message is determined to be suspicious, classifying the message according to its individual characteristics and its similarity to the noted message in the event that a similar ...
Improved nanoparticle type oligonucleotide structure having high efficiency and method for preparing same
Bioneer Corporation
June 01, 2017 - N°20170152512

The present invention relates to an oligonucleotide structure and a method for preparing the same and, more particularly, to an oligonucleotide structure in which a polymer compound is linked to an oligonucleotide via a covalent bond to improve in vivo stability of the oligonucleotide and cellular delivery efficiency of the oligonucleotide; and to a method for preparing the same. The ...
Loading